During the past decade, Imperial College Healthcare NHS Trust conducted 271 clinical trials. In the 10-year time frame, 271 clinical trials started and 73 clinical trials were completed, i.e. on average, 26.9% percent of trials that started reached the finish line to date. In the past 5 years, 119 clinical trials started and 36 clinical trials were completed. i.e. 30.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Imperial College Healthcare NHS Trust" #1 sponsor was "Imperial College London" with 155 trials, followed by "Imperial College Healthcare NHS Trust" with 26 trials sponsored, "Pfizer" with 11 trials sponsored, "Gilead Sciences" with 10 trials sponsored and "Incyte Corporation" with 10 trials sponsored. Other sponsors include 163 different institutions and companies that sponsored additional 115 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Imperial College Healthcare NHS Trust" #1 collaborator was "Imperial College Healthcare NHS Trust" with 30 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 20 trials as a collaborator, "Imperial College London" with 14 trials as a collaborator, "Medical Research Council" with 12 trials as a collaborator and "Cancer Research UK" with 9 trials as a collaborator. Other collaborators include 490 different institutions and companies that were collaborators in the rest 332 trials.

According to Clinical.Site data, the most researched conditions in "Imperial College Healthcare NHS Trust" are "Ovarian Cancer" (10 trials), "Prostate Cancer" (10 trials), "Pulmonary Arterial Hypertension" (8 trials), "Breast Cancer" (6 trials) and "HIV Infections" (6 trials). Many other conditions were trialed in "Imperial College Healthcare NHS Trust" in a lesser frequency.

Most popular intervention types in "Imperial College Healthcare NHS Trust" are "Drug" (177 trials), "Other" (68 trials), "Device" (36 trials), "Procedure" (36 trials) and "Biological" (22 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Paclitaxel" (7 trials), "Pembrolizumab" (6 trials), "Cisplatin" (4 trials) and "Dexamethasone" (4 trials). Other intervention names were less common.

The vast majority of trials in "Imperial College Healthcare NHS Trust" are 317 trials for "All" genders, 42 trials for "Female" genders and 21 trials for "Male" genders.

Currently, there are 178 active trials in "Imperial College Healthcare NHS Trust". 4 are not yet recruiting, 116 are recruiting, 57 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 139 completed trials in Imperial College Healthcare NHS Trust, 4 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Imperial College Healthcare NHS Trust, 37 "Phase 1" clinical trials were conducted, 85 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 71 trials that are defined as “Not Applicable".

Imperial College Healthcare NHS Trust has several departments that took part in Clinical trials: "Imperial College Respiratory Research Unit, St Mary's Hospital" - 4 trials, "Charing Cross Hospital; Imperial Memory Unit, Level 10 West" - 2 trials